Electrophysiological localization of the substantia nigra in the parkinsonian nonhuman primate

Journal of Neurosurgery

Volumn 93, Issue 4, 2000, Pages 704-710

  Starr, Philip A ^b   Subramanian, Thayagarajan ^b   Bakay, Roy A E ^b   Wichmann, Thomas ^b  

^a UCSF Medical Center at Parnassus   (United States)

^b NONE

Author keywords

Basal ganglia; Cell transplantation; Macaca mulatta; Microelectrode recording; Parkinson disease; Substantia nigra; Subthalamic nucleus

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; BRAIN ELECTROPHYSIOLOGY; BRAIN MAPPING; CELL TRANSPLANTATION; CONTROLLED STUDY; FEMALE; MACACA; MALE; MICROELECTRODE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 0034433642     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2000.93.4.0704     Document Type: Article

References (33)

1. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
2. Transient acute depression induced by high-frequency deep-brain stimulation
3. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus and of other nuclei as a treatment for Parkinson's disease
4. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of Parkinsonism
5. Single cell studies of the primate putamen. I. Functional organization
6. Activity of pallidal neurons during movement
7. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism
8. Functional recovery in parkinsonian monkeys treated with GDNF
9. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease
10. The subthalamic nucleus: A possible target for stereotaxic surgery in Parkinson's disease
11. The role of the subthalamic nucleus in the origin of hemiballism and parkinsonism: New surgical perspectives
12. Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque
13. Visual and oculomotor functions of monkey substantia nigra pars reticulata. I. Relation of visual and auditory responses to saccades
14. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease
15. Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients
16. Intranigral grafts of fetal ventral mesencephalic tissue in adult 6-hydroxydopamine-lesioned rats can induce behavioral recovery
17. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease
18. Methods for microstimulation and recording of single neurons and evoked potentials in the human central nervous system
19. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease
20. Methods for microelectrode-guided posteroventral pallidotomy
21. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease
22. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model
23. Fetal nigral transplantation as a therapy for Parkinson's disease
24. Ablative surgery and deep brain stimulation for Parkinson's disease
25. Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey
26. Neurophysiological properties of pallidal neurons in Parkinson's disease
27. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine
28. Microelectrode-guided pallidotomy: Technical approach and application for medically intractable Parkinson's disease
29. The primate subthalamic nucleus. I. Functional properties in intact animals
30. Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates
31. Inactivation of the substantia nigra pars reticulata ameliorates parkinsonian signs in MPTP-treated primates
32. Subthalamic nucleus stimulation for gait disturbance in Parkinson's disease